Member Info for Scinv_temp

The time to talk about iscib1+ has not come yet. Here is another new word for you, "priorities". I can't judge how trustworthy the company is based on data that they couldn't possibly have at the moment.

Great. But not much else to say that isn't wishy washy without any data. The reason I don't mention iscib1+ is because it's too early for that. But I don't like that the company was dishonest with investors that the trial would be fully recruited by end of 2023 when in fact it was 100% impossible for that to happen.

My opinion is based on current data. I don't say anything about modi because the combo with dual cpis started recently and it is good to see they are expanding. Other than that there is not much to say.

Last update I remember about iscib1+ was 4 patients recruited, early May iirc. The trial started recruiting around March. With scib 1 we have 4 data points start of recruitment sept 2019, 16 recruited Sept 2023, 21 patients Nov 2023 and 27 patients May 2024.

and you think most experts will recommend scancell over moderna/biontech/other large pharma? or do you think scancell is running the trials at more hospitals than the big boys? or do you think more oncologists work with scancell vs the big players that run multiple trials?

you are deluded. when scancell says that oncologists love the current method of delivery, they mean relative to electroporation they used previously which is a pain in the **** both for hospitals and patients.

you are fooling yourself if you think that the opinion of the general population does not matter when they are presented with choices.

Again, the level of the average sclp investor is pathetic. Let me repeat. If the patient is eligible for more than one trial, they can choose.

The oncologist advises fornwhich trial they are eligible and has a conversation with the patient. The patient absolutely has choice between trials, even if the oncologist recommends another, that they are eligible for. That's how it works.

Big companies have their money and marketing power to push their personalised. We have our data, and we are not using it. Do you think people who are reading articles like this that are constantly in popular media will chose scancell and not Moderna, biontech etc because we had a good interim readout last year? No one from the general population remembers that. We have one weapon as a small company and we are not using it, our data.

I'm talking about recruitment in the trials. If you actually do some DD you'll see that from 16 patients in 2 years (September 2019 - September 2023, excluding covid period) we went to 11 patients in 8 months (September 2023 - May 2024), that's actually a substantial improvement but the company failed to keep momentum.

Another thing that I just noticed on another forum. At the AGM (November 2023) the company said 21 patients had been recruited so that's 5 patients in 2 months after the announcement and then 6 patients in 6 months. It is clear that they would NEVER going to recruit all of the by EOY 2023 (even at the 5 patients/2 months which is huge relative to previous recruitment) but ALSO that the announcement back then had a significant impact on recruitment.

Another thing that I just noticed on another forum. At the AGM (November 2023) the company said 21 patients had been recruited so that's 5 patients in 2 months after the announcement and then 6 patients in 6 months. It is clear that they would NEVER going to recruit all of the by EOY 2023 (even at the 5 patients/2 months which is huge relative to previous recruitment) but ALSO that the announcement back then had a significant impact on recruitment.

Ps I mean in total, including hotel etc

It does. 3K to 5K per person depending on the conference since they pay commercial fees and not academic + hotel/other expenses

PS I'm talking about recruitment in the trials. If actually do some DD you'll see that from 16 patients in 2 years (September 2019 - September 2023, excluding covid period) we went to 11 patients in 8 months (September 2023 - May 2024), that's actually a substantial improvement but the company failed to keep momentum.

Big companies have their money and marketing power. We have our data, and we are not using it. Do you think people who are reading articles like this that are constantly in popular media will chose scancell and not Moderna, biontech etc because we had a good interim readout last year? No one from the general population remembers that. We have one weapon as a small company and we are not using it, our data.

When I demonstrated beyond doubt that it took us roughly 2 years to recruit 16 patients (September 2023) and therefore it was misleading for the company to say that they will complete recruitment of by end of 2023 and Burble/Bermuda (even if they are not the same person they always agree with eachother and move as one) replied that this is normal because they had some issues in January 2024, who is really trolling?

It sad to see the level of the average sclp inbestor. Which of the facts I presented constitutes trolling?

🤣🤣🤣🤣

For anyone curious, Stakis asked me to submit a question for the proactive event tonight, which is not possible because it is an in person event and also it was yesterday.

Great DD right there lmao

Nice strawman argument AGAIN. I guess you are slower than I thought, poor thing. The last presentation/poster on their website is from November 2023 and they have been to several conferences forums since then. They last update from any trial also from November 2023, apart from today to let us know they are adding an arm (how about a proper update from the current modi trial?). Hardly "day by day".

🤣🤣🤣🤣

Shut up Meg

Violin no way we get results (minimum one scan post treatment) from all required patients by Q4. More like Q2 2025 at this rate. I only note that earlier this month the CEO said Q3/Q4 and now apparently there are issues since January. They company needs to sort these things out with the investor community. Otherwise people are going to be reluctant and I assure you it's not just me.

Was that an indecent proposal Ruck?

And they still insist not to update investors properly so we have to rely on people attending meetings to get a glimpse of what they say. Kind investors here uploaded the recording of AGM on youtube and report back from the latest meeting and scancell cannot upload a presentation on their website and inform everyone of current status and plans properly. If you like to be treated like crap, be my guest, but not everyone likes it.